High-performance transfection reagents engineered for scalable, efficient and reliable gene delivery across cell and gene therapy, viral vector production and protein expression workflows.
Branca Bunús develops advanced HPAE polymer-based technologies designed to help researchers, CDMOs, biotech and pharmaceutical companies accelerate life science breakthroughs with improved transfection performance, scalability and cost-efficiency.
Or contact us at info@brancabunus.com
Branca Bunús Ltd is a gene therapy and biotechnology company focused on developing safe gene medicines and potent transfection reagents. Through its HPAEs platform technology, the company advances high-performance non-viral gene delivery vectors for modern life science applications.
Polymer engineering for non-viral delivery
Next-generation transfection product line
Workflows from R&D to production-scale
Biotech and CDMO partnerships worldwide
Engineered polymer chemistry for non-viral payload delivery.
HPAE polymer-based delivery, stable complex formation, broad payload compatibility and scalability from R&D to larger production workflows.
pDNA, siRNA, mRNA and CRISPR complexes for targeted delivery applications.
Easy preparation and super-stable transfection complexes designed to support reliable workflows.
Engineered to support improved transfection efficiency while maintaining strong cell viability.
Designed for academic research, biotech development and CDMO production environments.
Support scalable workflows for viral vector transient production in cell and gene therapy.
Enable efficient protein expression workflows with reliable transfection performance.
Designed to streamline gene delivery processes for next-generation therapeutic development.
Support researchers and development teams working with demanding delivery requirements.
Built to transition from lab-scale testing to larger production-oriented workflows.
Tailored designs and formulations for specific delivery needs involving pDNA, siRNA, mRNA and CRISPR complexes.
A high-performance reagent platform developed to support efficient, scalable and cost-effective transfection workflows.
BrPERfect® is Branca Bunús' next-generation transfection reagent technology, developed through its HPAE polymer-based platform. The reagent is designed for life science teams seeking greater reliability, scalability and workflow efficiency in demanding gene delivery applications.
Expert technical support and training to help teams succeed at every stage.
High-efficiency transfection reagents designed to support demanding applications.
From small academic labs to large-scale CDMO production, the platform is designed to scale with workflow needs.
Premium-quality reagent technology built to help reduce costs while improving process performance.
Tailored designs and formulations for targeted delivery of pDNA, siRNA, mRNA and CRISPR complexes.
Already adopted by CDMOs and biotech partners in real-world development environments.
Branca Bunús has achieved certification from the National Standards Authority of Ireland (NSAI) confirming that its Quality Management System meets ISO 9001:2015 requirements.
Branca Bunús has submitted a Drug Master File to the FDA for its lead HPAE polymer-based transfection reagent and received confirmation as a DMF holder, DMF number 39924, from June 2024.
The company's QMS covers processes, procedures and responsibilities involved in developing and manufacturing its products, including the BrPERfect® series.
“Quality is not a support function. It is part of the platform.”
Branca Bunús and Duoning Biotech are collaborating on the co-development and commercialization of BrPERfect® next-generation transfection reagents, aiming to deliver high-performance gene delivery solutions for biopharmaceutical companies in China and beyond.
Professor Wenxin Wang, founder of Branca Bunús and Research Ireland Principal Investigator at the UCD Charles Institute of Dermatology, received the 2025 NovaUCD Innovation Award in recognition of excellence in innovation and commercialization of UCD research.
Request press releaseThe meeting marked a significant milestone in the strategic partnership focused on co-developing and commercializing BrPERfect® next-generation transfection reagents.
Read moreThe companies are collaborating on the development, optimization and application of transfection reagents to support upstream bioprocessing innovation.
Read moreBranca Bunús reached a key regulatory milestone with the successful submission of a Drug Master File for its lead HPAE polymer-based transfection reagent.
Read moreThe company's Quality Management System has been certified by NSAI, supporting quality confidence across product development and manufacturing.
Read moreFounder
Founder of Branca Bunús and a leading researcher connected with UCD's Charles Institute of Dermatology and UCD School of Medicine. His work and innovation leadership have contributed to the development and commercialization of advanced gene delivery technologies.
Managing Director & CEO
Managing Director and CEO of Branca Bunús, leading the company's strategy, partnerships and operational growth across international biotech and biopharmaceutical markets.
Speak with the Branca Bunús team about transfection performance, workflow scalability, custom formulations or partnership opportunities.
